<?xml version="1.0" encoding="UTF-8"?>
<p>More than half of patients did not follow up after diagnosis of acute HBV, and therefore their clearance status could not be determined. Seventeen patients had follow-up HBsAg testing, and 1 (6%) developed chronic HBV infection. This patient was co-infected with HIV, and his antiretroviral regimen included lamivudine as the only drug active against HBV. One patient with Crohnâ€™s disease, who was on treatment with mesalamine at the time of the infection, cleared the HBsAg by the 14th month after acute illness.</p>
